Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 26
- Registration Number
- NCT00649870
- Locations
- 🇺🇸
Kendle International Inc., Morgantown, West Virginia, United States
Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 119
- Registration Number
- NCT00650520
- Locations
- 🇨🇦
MDS Pharma Services, Montreal, Quebec, Canada
Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 54
- Registration Number
- NCT00649935
- Locations
- 🇺🇸
Kendle International Inc., Morgantown, West Virginia, United States
Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 47
- Registration Number
- NCT00648024
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 32
- Registration Number
- NCT00648700
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Fasting Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 60
- Registration Number
- NCT00649103
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 20
- Registration Number
- NCT00649116
- Locations
- 🇺🇸
Kendle International Inc., Morgantown, West Virginia, United States
Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 27
- Registration Number
- NCT00649948
- Locations
- 🇺🇸
Kendle International Inc., Morgantown, West Virginia, United States
Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 54
- Registration Number
- NCT00650273
- Locations
- 🇺🇸
Kendle International Inc., Morgantown, West Virginia, United States
Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 68
- Registration Number
- NCT00649376
- Locations
- 🇺🇸
Kendle International Inc., Morgantown, West Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath